15 Additional Drugs Chosen For Medicare Negotiation
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
By Rick Amato November 14, 2024 (Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
The Food and Drug Administration (FDA) has approved the weight-loss drug Wegovy to reduce heart attack and stroke risk.
The diabetic treatment Ozempic, which has gained popularity for not only diabetes but weight loss too, now lists clogged intestines as a side effect on the label.